Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001213900-17-002573
Filing Date
2017-03-20
Accepted
2017-03-20 10:32:24
Documents
5

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 8 TO FORM F-1 ff12016a8_therapixbioscience.htm F-1/A 3510128
2 FORM OF UNDERWRITING AGREEMENT BY AND AMONG THERAPIX BIOSCIENCES LTD. AND THE UN ff12016a8ex1i_therapixbio.htm EX-1.1 371314
3 CONSENT OF KOST FORER GABBAY & KASIERER ff12016a8ex23i_therapixbio.htm EX-23.1 2682
4 GRAPHIC image_001i.jpg GRAPHIC 6295
5 GRAPHIC image_002.jpg GRAPHIC 3119
  Complete submission text file 0001213900-17-002573.txt   3898394
Mailing Address SCIENCE PARK, 18 EINSTIEN ST. P.O BOX 4122 NESS-ZIONA L3 7414002
Business Address SCIENCE PARK, 18 EINSTIEN ST. P.O BOX 4122 NESS-ZIONA L3 7414002 972-8-9396577
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: F-1/A | Act: 33 | File No.: 333-214458 | Film No.: 17700431
SIC: 2834 Pharmaceutical Preparations